Thenappan Thenappan
Expertise in
11
conditions

Dr. Thenappan Thenappan

Cardiology | Transplant Surgery
909 Fulton Street Southeast, Suite 318, 
Minneapolis, MN 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
11
conditions
909 Fulton Street Southeast, Suite 318, 
Minneapolis, MN 

Overview

Thenappan Thenappan is a Transplant Surgeon practicing medicine in Minneapolis, Minnesota.

Dr. Thenappan is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Hypertension, Heart Failure with Preserved Ejection Fraction (HFpEF), Angioplasty, and Heart Transplant.

Dr. Thenappan is board certified in Advanced Heart Failure And Transplant Cardiology: American Board Of Internal Medicine, 2014 and Cardiovascular Disease: American Board Of Internal Medicine, 2012. He is actively involved in clinical research, co-authoring 121 peer reviewed articles and participating in 7 clinical trials. Dr. Thenappan is currently accepting new patients.

Residency

Madras Medical College, Internal Medicine - 2002

Specialties

Cardiology
Transplant Surgery

Licenses

Internal Medicine in MN

Board Certifications

Advanced Heart Failure And Transplant Cardiology: American Board Of Internal Medicine, 2014
Cardiovascular Disease: American Board Of Internal Medicine, 2012

Fellowships

University of Chicago Medicine, Advanced Heart Failure - 2013
University of Chicago Medicine, Cardiovascular Disease - 2012

Hospital Affiliations

Essentia Health St Mary's Medical Center
M Health Fairview Woodwinds Hospital
M Health Fairview University Of Mn Medical Center
M Health Fairview Southdale Hospital
M Health Fairview St John's Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Metropolitan Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
PreferredOne
  • HMO
  • OTHER COMMERCIAL
Sanford
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Sanford Health
  • HMO
  • PPO
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS
South Country Health Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

M Health Fairview Heart Clinic Fulton
909 Fulton Street Southeast, Suite 318, Minneapolis, MN 55455
Other Locations
M Health Fairview Heart Care Woodbury
1875 Woodwinds Drive, Suite 110 Woodwinds Birch Center, Woodbury, MN 55125

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

An Early Feasibility Study Assessing Treatment of Pulmonary Hypertension Using the Aria CV Pulmonary Hypertension System
An Early Feasibility Study Assessing Treatment of Pulmonary Hypertension Using the Aria CV Pulmonary Hypertension System
Enrollment Status: Recruiting
Publish Date: September 29, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept Versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) Due to Heart Failure With Preserved Ejection Fraction (HFpEF)
A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept Versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) Due to Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Completed
Publish Date: April 15, 2026
Intervention Type: Drug
Study Drug: Sotatercept
Study Phase: Phase 2
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
Beta-blockers in Pulmonary Arterial Hypertension - A Phase 2 Double-Blind, Placebo-Controlled, Crossover Study Evaluating the Efficacy, and Safety of Carvedilol for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
Beta-blockers in Pulmonary Arterial Hypertension - A Phase 2 Double-Blind, Placebo-Controlled, Crossover Study Evaluating the Efficacy, and Safety of Carvedilol for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 16, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

121 Total Publications

Incident Atrial Fibrillation and Flutter in Patients With Pulmonary Arterial Hypertension: Influence of Right Ventricular Dilatation and Reduced Right Atrial Function.
Incident Atrial Fibrillation and Flutter in Patients With Pulmonary Arterial Hypertension: Influence of Right Ventricular Dilatation and Reduced Right Atrial Function.
Journal: Journal of the American Heart Association
Published: April 20, 2026
Similar Doctors
Expertise in
15
conditions
Dr. Timothy Pruett
Transplant Surgery | General Surgery
Expertise in
15
conditions
Dr. Timothy Pruett
Transplant Surgery | General Surgery
Referral may be required

M Health Fairview Transplant Clinic

909 Fulton Street Southeast, Suite 300, 
Minneapolis, MN 
 (3.3 miles away)
612-625-5115
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Timothy Pruett is a General Surgeon and a Transplant Surgeon practicing medicine in Minneapolis, Minnesota. Dr. Pruett is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Chronic Pancreatitis, Hereditary Pancreatitis, Childhood Pancreatitis, Pancreatectomy, and Kidney Transplant. Dr. Pruett is board certified in Surgical Critical Care: American Board Of Surgery, 1989, Surgery (General Surgery): American Board Of Surgery, 1987, Infectious Disease: American Board Of Internal Medicine, 1984, and Internal Medicine: American Board Of Internal Medicine, 1982. Dr. Pruett is currently accepting new patients.

Expertise in
12
conditions
Dr. Paul Orchard
Transplant Surgery | Pediatrics | Pediatric Hematology Oncology
Expertise in
12
conditions
Dr. Paul Orchard
Transplant Surgery | Pediatrics | Pediatric Hematology Oncology
Referral may be required

M Health Fairview Center For Pediatric Blood And Marrow Transplant And Celluar Therapy

Journey Clinic Riverside East 9th, Floor 2450 Riverside Ave, 
Minneapolis, MN 
 (3.6 miles away)
612-365-8100
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Paul Orchard is a Pediatrics specialist and a Pediatric Hematologist Oncology provider practicing medicine in Minneapolis, Minnesota. Dr. Orchard is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Adrenoleukodystrophy (ALD), Adrenal Insufficiency Pediatric, Metachromatic Leukodystrophy, Bone Marrow Transplant, and Osteotomy. Dr. Orchard is currently accepting new patients.

Expertise in
10
conditions
Dr. Michelle Rheault
Transplant Surgery | Pediatric Nephrology
Expertise in
10
conditions
Dr. Michelle Rheault
Transplant Surgery | Pediatric Nephrology
Referral may be required

M Health Fairview Pediatric Specialty Clinic Woodbury

9680 Tamarack Road, Suite 130, 
Woodbury, MN 
 (12.9 miles away)
612-365-6777
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michelle Rheault is a Pediatric Nephrologist and a Transplant Surgeon practicing medicine in Woodbury, Minnesota. Dr. Rheault is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Alport Syndrome, Focal Segmental Glomerulosclerosis, Nephrotic Syndrome, Glomerulonephritis, and Kidney Transplant. Dr. Rheault is board certified in Pediatric Nephrology: American Board Of Pediatrics, 2005 and Pediatrics: American Board Of Pediatrics, 2002. Dr. Rheault is currently accepting new patients.

Frequently Asked Questions about Dr. Thenappan Thenappan

How do I make an appointment with Dr. Thenappan Thenappan?

You can book an appointment with Dr. Thenappan Thenappan by calling their office at 612-365-5000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Thenappan Thenappan a top-rated expert for Pulmonary Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Thenappan Thenappan is classified as an Elite expert for Pulmonary Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Thenappan Thenappan specialize in?

While Dr. Thenappan Thenappan is a Cardiology, they have specific expertise in Pulmonary Hypertension, Hypertension, and Heart Failure with Preserved Ejection Fraction (HFpEF). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Cardiology.

Does Dr. Thenappan Thenappan participate in research or clinical trials?

Yes. Dr. Thenappan Thenappan has published 121 articles and abstracts on conditions like Pulmonary Hypertension. You can view a list of Dr. Thenappan Thenappan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Thenappan Thenappan accept my insurance?

Dr. Thenappan Thenappan accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 612-365-5000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Thenappan's expertise for a condition
ConditionClose
View All 30 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile